Clinical Trials Logo

Intervertebral Disc Degeneration clinical trials

View clinical trials related to Intervertebral Disc Degeneration.

Filter by:

NCT ID: NCT03640338 Withdrawn - Clinical trials for Degenerative Disc Disease

The Efficacy of Continuous Cold-Therapy on Postoperative Pain and Narcotics Use Following Spinal Fusion

Start date: April 2020
Phase: N/A
Study type: Interventional

Patient outcomes and satisfaction are an ever-increasing priority in surgical specialties. Cryotherapy has been utilized following spine surgery as an adjunct therapy to reduce postoperative inflammation and improve patient outcomes. However, limited studies have investigated the effect of cryotherapy on postoperative pain and narcotics use. Fountas et al. performed a randomized controlled trial to assess the impact of postoperative cryotherapy following single-level lumbar microdiscectomy. The authors reported patients receiving cryotherapy required significantly less pain medication (0.058 mg/kg/hr versus 0.067 mg/kg/hr, p<0.001) and had shorter hospital stays (1.71 days versus 2.65 days, p<0.001) as compared to the control group. In another randomized trial of single-level lumbar discectomy patients, Murata et al. demonstrated cryotherapy to have no significant effect on VAS inpatient pain scores or postoperative blood loss.

NCT ID: NCT03513445 Withdrawn - Clinical trials for Degenerative Disc Disease

Peri-Incisional Drug Injection in Lumbar Spine Surgery

Start date: June 1, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized prospective study that will compare the use of narcotics in a control group of non-injected patients with a treatment arm of patients injected intra-operatively with a ropivacaine, morphine, and epinephrine cocktail. The investigators hypothesize that this treatment will reduce narcotic use in patients during their hospital stay, and possibly decrease the length of their stay in the hospital.The investigators also hope their pain will be decreased as displayed by their multi-daily Clinically Aligned Pain Assessment (CAPA) score.

NCT ID: NCT03418649 Withdrawn - Low Back Pain Clinical Trials

Eplerenone as a Supplement to Epidural Steroid Injections

Start date: June 2023
Phase: Phase 4
Study type: Interventional

Low back pain is a leading cause of disability and health care costs in the United States, and treatments are ineffective for many patients. Epidural steroid injections are a common treatment, but their efficacy has been questioned and for many patients they do not provide complete relief. The investigators hypothesize, based on preclinical studies, that lack of complete efficacy may be due to the fact that clinically used steroids activate not only the intended drug target, the glucocorticoid receptor, but also the pro-inflammatory mineralocorticoid receptor. To test this hypothesis, this pilot study will recruit patients scheduled for lumbar epidural steroid injections for degenerative disc disease, and randomize them to receive a concurrent treatment with oral eplerenone (a clinically approved antagonist of the mineralocorticoid receptor) or placebo for 10 days starting just after the epidural injection. At several time points during the following year, subjects will answer the Oswestry Low Back Pain Questionnaire, to report on both pain and functional outcomes.

NCT ID: NCT03327272 Withdrawn - Clinical trials for Degenerative Disc Disease

Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion

Start date: May 22, 2018
Phase: Phase 3
Study type: Interventional

Neural injury is a well-known complication following extreme lateral lumbar interbody fusion (XLIF). It has been found that up to 9.4% of patients will have either temporary or persistent neurologic deficit. This occurs with traversal of the psoas muscle or direct injury to lumbosacral plexus or sympathetic ganglion. While often temporary, it can cause hip flexor weakness, thigh numbness, or pain. Several studies have demonstrated reduced patient reported pain scores following steroid administration, particularly in the early postoperative period. However, few studies have investigated the efficacy of intraoperative local injection of corticosteroid in reducing the incidence and duration of postoperative pain or neurologic injury for XLIF patients.

NCT ID: NCT03312192 Withdrawn - Clinical trials for Degenerative Disc Disease

Stand-Alone Cage Verus Anterior Plating for Anterior Cervical Discectomy and Fusion.

Start date: July 17, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the clinical results between two different techniques for ACDF: 1. Stand-alone ACDF, which means the placement of an interbody device (cage) without anterior fixation or plating; 2. ACDF with and interbody cage and anterior plating for fixation. Both of these procedures are commonly performed at Rush with unclear advantage of one procedure over the other. Both have been associated with good to excellent clinical outcomes. The devices used in this study are approved by the Food and Drug Administration (FDA).

NCT ID: NCT03223701 Withdrawn - Clinical trials for Degenerative Disc Disease

Efficacy of Using Solum IV and BMC With GFC in TLIF

Start date: September 30, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the efficacy of using Solum IV and bone marrow concentrate with general fluid concentrate in Transforaminal Lumbar Interbody Fusion (TLIF).

NCT ID: NCT03187171 Withdrawn - Surgery Clinical Trials

ACDF Comparison Trial

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

This research protocol seeks to compare radiological and clinical outcomes of cervical spine disease patients following standard-of-care anterior cervical discectomy and fusion (ACDF) using allograft fusion versus Cohere porous polyetheretherketone (PEEK) fusion device. This clinical study presents little to no additional risk to study subjects beyond those associated with standard-of-care ACDF surgery. Adults age 18 and over who are undergoing an ACDF procedure will be enrolled in the study. The study consists of a completing a series of questionnaires and obtaining radiographs. The primary endpoint of the study will be the rate of successful spinal fusion for each group. For evaluation of the primary endpoint and additional assessments, descriptive statistics including mean, standard deviation, minimum, median, and maximum for continuous variables and frequency distribution for categorical variables will be provided, as well as tabular listings. All complications will be itemized including incidence, duration, and relationship to the device used and/or procedures performed.

NCT ID: NCT03162666 Withdrawn - Clinical trials for Degenerative Disc Disease

Patient Outcomes Using an Expandable Spacer

Start date: February 28, 2017
Phase:
Study type: Observational

This study is a post-market clinical follow-up study. The data collected from this study will serve the purpose of confirming safety and performance of the ALTERA™ Expandable implant.

NCT ID: NCT02998060 Withdrawn - Spondylolisthesis Clinical Trials

Clinical Evidence of Robot Guided vs. Navigated vs. Free Hand Lumbar Spinal Fusion

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Computer-based navigation systems were first introduced to spine surgery in 1995 and while they have been long established as standards in certain cranial procedures, they have not been similarly adopted in spine surgery. Designed to overcome some of the limitations of navigation-based technologies, robot-guided surgical systems have become commercially available to surgeons worldwide.These systems are rapidly challenging the gold standards. The aim is to conduct a prospective randomized controlled trial. The randomized variable will be the screw placement technique used. One arm will be treated with lumbar fusion using robotic guidance (RG), one arm will receive the same procedure but with a free hand technique (FH) and the third arm will use navigation (NV) (CT or Fluoroscopy-assisted). Intraoperative screw revisions and revision surgery for screw malposition as well as clinical patient-reported outcomes to identify any such differences between these methods of screw insertion will be assessed.

NCT ID: NCT02496364 Withdrawn - Clinical trials for Surgical Procedure, Unspecified

Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease

Start date: March 1, 2014
Phase: N/A
Study type: Interventional

Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease